Literature DB >> 21651436

The virology and developments toward control of human enterovirus 71.

Lina Yi1, Jing Lu, Hsiang-Fu Kung, Ming-Liang He.   

Abstract

Enterovirus 71 (EV71), a member of the Enterovirus genus in the Picornaviridae family, was first recognized as a dermotrophic virus that usually cause mild, self-limiting hand-foot-and-mouth disease (HFMD). However, EV71 infection can sometimes induce a variety of severe neurological complications and even death. Current large outbreaks of EV71 make this virus being a major public health issue. Intense effort has been made to address its underlying pathogenesis and to develop effective means for combating EV71 infections. Here, we aimed to provide an overview of cellular mechanisms underlying EV71 infection and to assess potential agents for prevention and treatment of EV71 infections.

Entities:  

Mesh:

Year:  2011        PMID: 21651436     DOI: 10.3109/1040841X.2011.580723

Source DB:  PubMed          Journal:  Crit Rev Microbiol        ISSN: 1040-841X            Impact factor:   7.624


  45 in total

1.  Enterovirus 71 suppresses interferon responses by blocking Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling through inducing karyopherin-α1 degradation.

Authors:  Chunyang Wang; Menghuai Sun; Xinhui Yuan; Lianfu Ji; Yu Jin; Carol J Cardona; Zheng Xing
Journal:  J Biol Chem       Date:  2017-04-28       Impact factor: 5.157

2.  Immunogenicity and protective efficacy of an EV71 virus-like particle vaccine against lethal challenge in newborn mice.

Authors:  Shiyang Sun; Fan Gao; Qunying Mao; Jie Shao; Liping Jiang; Dawei Liu; Yiping Wang; Xin Yao; Xing Wu; Bo Sun; Dandan Zhao; Youlei Ma; Jingcai Lu; Wei Kong; Chunlai Jiang; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Enterovirus 71 Proteins 2A and 3D Antagonize the Antiviral Activity of Gamma Interferon via Signaling Attenuation.

Authors:  Li-Chiu Wang; Su-O Chen; Shih-Ping Chang; Yi-Ping Lee; Chun-Keung Yu; Chia-Ling Chen; Po-Chun Tseng; Chia-Yuan Hsieh; Shun-Hua Chen; Chiou-Feng Lin
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

4.  A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection.

Authors:  Wei Xin Khong; Benedict Yan; Huimin Yeo; Eng Lee Tan; Jia Jun Lee; Jowin K W Ng; Vincent T Chow; Sylvie Alonso
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

Review 5.  Therapeutic and prevention strategies against human enterovirus 71 infection.

Authors:  Chee Choy Kok
Journal:  World J Virol       Date:  2015-05-12

6.  The Pathogenesis and Prevention of Encephalitis due to Human Enterovirus 71.

Authors:  Emily Jane Bek; Peter Charles McMinn
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

7.  Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1.

Authors:  Jing Lu; Lina Yi; Jin Zhao; Jun Yu; Ying Chen; Marie C Lin; Hsiang-Fu Kung; Ming-Liang He
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

8.  Molecular surveillance of coxsackievirus A16 in southern China, 2008-2019.

Authors:  Lina Yi; Hanri Zeng; Huanying Zheng; Jinju Peng; Xue Guo; Leng Liu; Qianling Xiong; Limei Sun; Xiaohua Tan; Jianfeng He; Jing Lu; Hui Li
Journal:  Arch Virol       Date:  2021-04-01       Impact factor: 2.574

9.  Prevalence of nonpolio enteroviruses in the sewage of Guangzhou city, China, from 2009 to 2012.

Authors:  Huanying Zheng; Jing Lu; Yong Zhang; Hiromu Yoshida; Xue Guo; Leng Liu; Hui Li; Hanri Zeng; Ling Fang; Yanling Mo; Lina Yi; Toru Chosa; Wenbo Xu; Changwen Ke
Journal:  Appl Environ Microbiol       Date:  2013-10-04       Impact factor: 4.792

10.  Comprehensive safety assessment of a human inactivated diploid enterovirus 71 vaccine based on a phase III clinical trial.

Authors:  Wei Zhang; Yujia Kong; Zhiwei Jiang; Chanjuan Li; Ling Wang; Jielai Xia
Journal:  Hum Vaccin Immunother       Date:  2016-02-02       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.